Clinical Trial Update: VEG111485: A QTc Study of Pazopanib [Phase 1]

View source ↗

Summary

This update covers the completion of a Phase 1 QTc study evaluating pazopanib in renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Phase 1 | Status: COMPLETED